Neuroprotective effects of N-alkyl-1,2,4-oxadiazolidine-3,5-diones and their corresponding synthetic intermediates N-alkylhydroxylamines and N-1-alkyl-3-carbonyl-1-hydroxyureas against in vitro cerebral ischemia
Mots clés
Animals
Brain Ischemia/*drug therapy
Hydroxylamines/chemical synthesis/*chemistry/therapeutic use
Hydroxyurea/chemical synthesis/*chemistry/therapeutic use
JNK Mitogen-Activated Protein Kinases/metabolism
Mice
Neuroprotective Agents/*chemical synthesis/chemistry/therapeutic use
Oxadiazoles/chemical synthesis/*chemistry/therapeutic use
p38 Mitogen-Activated Protein Kinases/metabolism
Cell Line
Extracellular Signal-Regulated MAP Kinases/metabolism